Company Filing History:
Years Active: 2017-2020
Title: Innovations and Contributions of Inventor Bin Li
Introduction
Bin Li is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of therapeutic agents, particularly in predicting responses to treatment. With a total of 2 patents, his work has implications for improving patient outcomes in medical treatments.
Latest Patents
Bin Li's latest patents include "Biomarkers and methods to predict response to inhibitors and uses thereof." This patent discloses markers associated with sensitivity to treatment with therapeutic agents. It outlines methods to identify these markers for predicting treatment outcomes and provides compositions to predict responses to NAE inhibition or EGFR inhibition treatment. Another significant patent is "Biomarkers of response to NAE inhibitors," which details markers whose mutational status is linked to sensitivity to NAE inhibitors. This patent emphasizes the importance of assessing marker genes to predict responses to treatment.
Career Highlights
Bin Li is currently associated with Millennium Pharmaceuticals Limited, where he applies his expertise in the development of innovative therapeutic solutions. His work focuses on enhancing the efficacy of treatments through the identification of predictive biomarkers.
Collaborations
Some of his notable coworkers include Stephen J Blakemore and George J Mulligan, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Bin Li's contributions to the field of therapeutics through his patents and collaborative work highlight his role as an influential inventor. His research continues to pave the way for advancements in predicting treatment responses, ultimately benefiting patient care.